Literature DB >> 22969971

Clinical significance of immunohistochemical expression of insulin-like growth factor-1 receptor and matrix metalloproteinase-7 in resected non-small cell lung cancer.

Taketsugu Yamamoto1, Takashi Oshima, Kazue Yoshihara, Teppei Nishi, Hiromasa Arai, Kenji Inui, Takeshi Kaneko, Akinori Nozawa, Hiroyuki Adachi, Yasushi Rino, Munetaka Masuda, Toshio Imada.   

Abstract

Insulin-like growth factor-1 receptor (IGF-1R) and matrix metalloproteinase-7 (MMP-7) have been reported to be related to tumor invasion and metastasis in various malignancies. The aim of this study was to evaluate the expression levels of IGF-1R and MMP-7 in resected non-small cell lung cancer (NSCLC) and to examine the relationship of such levels to clinical characteristics and survival. Expression was measured immunohistochemically. The percentage of stained cells was multiplied by the staining intensity. The sample was classified as high when the score was equal or higher than the median value or was otherwise considered to be low. High IGF-1R expression was associated with nodal metastasis and recurrence (P=0.034 and 0.006, respectively). High IGF-1R expression was associated with significantly poorer overall survival than low IGF-1R expression (P=0.011). MMP-7 expression did not significantly correlate with any clinicopathological factor. There was a trend toward slightly, but not significantly poorer survival in patients with MMP-7-high tumors than in those with MMP-7-low tumors (P=0.220). There was no significant correlation between IGF-1R expression and MMP-7 expression (P=0.184). Upon multivariate analysis, IGF-1R expression was independently related to the outcomes of patients with NSCLC. Overexpression of IGF-1R may be a useful predictor of lymph node metastasis, recurrence and post-surgical outcomes in patients with NSCLC.

Entities:  

Year:  2012        PMID: 22969971      PMCID: PMC3438550          DOI: 10.3892/etm.2012.493

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  19 in total

Review 1.  Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.

Authors:  Robert Visse; Hideaki Nagase
Journal:  Circ Res       Date:  2003-05-02       Impact factor: 17.367

2.  The IGF-I receptor in cell growth, transformation and apoptosis.

Authors:  R Baserga; A Hongo; M Rubini; M Prisco; B Valentinis
Journal:  Biochim Biophys Acta       Date:  1997-06-07

Review 3.  Role of the IGF-I receptor in mutagenesis and tumor promotion.

Authors:  V A Blakesley; B S Stannard; T Kalebic; L J Helman; D LeRoith
Journal:  J Endocrinol       Date:  1997-03       Impact factor: 4.286

4.  Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression.

Authors:  Rafal Dziadziuszko; Daniel T Merrick; Samir E Witta; Adelita D Mendoza; Barbara Szostakiewicz; Amelia Szymanowska; Witold Rzyman; Katarzyna Dziadziuszko; Jacek Jassem; Paul A Bunn; Marileila Varella-Garcia; Fred R Hirsch
Journal:  J Clin Oncol       Date:  2010-03-29       Impact factor: 44.544

5.  Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, beta-catenin and prognosis.

Authors:  Tero Leinonen; Risto Pirinen; Jan Böhm; Risto Johansson; Kirsi Ropponen; Veli-Matti Kosma
Journal:  Lung Cancer       Date:  2006-01-19       Impact factor: 5.705

6.  Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.

Authors:  Yasushi Adachi; Rong Li; Hiroyuki Yamamoto; Yongfen Min; Wenhua Piao; Yu Wang; Arisa Imsumran; Hua Li; Yoshiaki Arimura; Choon-Taek Lee; Kohzoh Imai; David P Carbone; Yasuhisa Shinomura
Journal:  Carcinogenesis       Date:  2009-06-03       Impact factor: 4.944

7.  Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

Authors:  F Cappuzzo; G Tallini; G Finocchiaro; R S Wilson; C Ligorio; L Giordano; L Toschi; M Incarbone; R Cavina; L Terracciano; M Roncalli; M Alloisio; M Varella-Garcia; W A Franklin; A Santoro
Journal:  Ann Oncol       Date:  2009-09-18       Impact factor: 32.976

8.  Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer.

Authors:  Tomoko Kitoh; Hideo Yanai; Yuki Saitoh; Youhei Nakamura; Yoshitaka Matsubara; Hideaki Kitoh; Tomoharu Yoshida; Kiwamu Okita
Journal:  J Gastroenterol       Date:  2004       Impact factor: 7.527

Review 9.  The insulin-like growth factor system and cancer.

Authors:  Derek LeRoith; Charles T Roberts
Journal:  Cancer Lett       Date:  2003-06-10       Impact factor: 8.679

10.  High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

Authors:  V Ludovini; G Bellezza; L Pistola; F Bianconi; L Di Carlo; A Sidoni; A Semeraro; R Del Sordo; F R Tofanetti; M G Mameli; G Daddi; A Cavaliere; M Tonato; L Crinò
Journal:  Ann Oncol       Date:  2009-01-19       Impact factor: 32.976

View more
  11 in total

Review 1.  The links between insulin resistance, diabetes, and cancer.

Authors:  Etan Orgel; Steven D Mittelman
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

2.  Prognostic value of matrix metalloproteinase-7 expression in patients with non-small cell lung cancer.

Authors:  Yonggang Liang; Shanxian Guo; Qinghua Zhou
Journal:  Tumour Biol       Date:  2013-12-14

Review 3.  Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.

Authors:  Shuang Zhao; Zhixin Qiu; Jinlan He; Lei Li; Weimin Li
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

4.  Mutational analysis of the insulin-like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients.

Authors:  Kathy Gately; Lydia Forde; Stephen Gray; Derek Morris; Aidan Corvin; Prerna Tewari; Kenneth O'Byrne
Journal:  Mol Clin Oncol       Date:  2015-06-11

5.  Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Authors:  Jin-Soo Kim; Edward S Kim; Diane Liu; J Jack Lee; Luisa Solis; Carmen Behrens; Scott M Lippman; Waun Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Clin Lung Cancer       Date:  2014-01-01       Impact factor: 4.785

6.  Correlations of IGF-1R and COX-2 Expressions with Ras and BRAF Genetic Mutations, Clinicopathological Features and Prognosis of Colorectal Cancer Patients.

Authors:  Mei Jin; Zi-Wen Long; Jing Yang; Xiang Lin
Journal:  Pathol Oncol Res       Date:  2017-02-10       Impact factor: 3.201

7.  Elevated matrix metalloproteinase-7 expression promotes metastasis in human lung carcinoma.

Authors:  Ji-Chang Han; Xian-Dong Li; Jin Du; Feng Xu; Yu-Ju Wei; Hong-Bing Li; Yi-Jie Zhang
Journal:  World J Surg Oncol       Date:  2015-01-14       Impact factor: 2.754

8.  Celecoxib inhibits insulin-like growth factor 1 induced growth and invasion in non-small cell lung cancer.

Authors:  Chen-Hui Liu; Hong-Guang Bao; Ya-Li Ge; Shu-Kui Wang; Yan Shen; Li Xu
Journal:  Oncol Lett       Date:  2013-03-29       Impact factor: 2.967

9.  MMP-7 is upregulated by COX-2 and promotes proliferation and invasion of lung adenocarcinoma cells.

Authors:  J Zhang; J Luo; J Ni; L Tang; H P Zhang; L Zhang; J F Xu; D Zheng
Journal:  Eur J Histochem       Date:  2014-02-18       Impact factor: 3.188

10.  Roles of osteopontin and matrix metalloproteinase-7 in occurrence, progression, and prognosis of nonsmall cell lung cancer.

Authors:  Ying Sun; Dan Li; Xiao-Hong Lv; Shu-Cheng Hua; Ji-Chang Han; Feng Xu; Xian-Dong Li
Journal:  J Res Med Sci       Date:  2015-12       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.